Objectives: The aim of the present study was to report on the survival of dental implants placed in conjunction with nasal floor elevation.
Methods: A retrospective cohort of 32 consecutive patients from two private practices was evaluated. All patients presented with alveolar bone height deficiency in the anterior region, which was not sufficient to place a dental implant according to a computed tomography (CT) scan preformed prior to implantation. Elevation and augmentation of the nasal mucosa was performed simultaneously with dental implant placement. Data collection included demographic information, as well as records of the pre-operative available bone height, implant dimensions, bone addition following nasal floor augmentation, and survival of the implants at last follow-up.
Results: Overall, 32 patients received 100 implants that were performed in conjunction with nasal floor elevation. The average pre-operative available bone height according to a CT scan that was preformed prior to implantation was 9.1 ± 0.9 mm and ranged from 7.3 to 11.2 mm. Bone addition following nasal floor augmentation was 3.4 ± 0.9 mm and ranged between 1.1 and 5.7 mm. The mean follow-up time was 27.8 ± 12.4 months, and during that follow-up period, no implant failure was recorded, resulting in 100% implant survival.
Conclusion: Nasal floor elevation might serve as a predictable procedure, which allows implant placement in areas with significant atrophy together with increased implant stability due to the bicortical support.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1708-8208.2010.00312.x | DOI Listing |
Ear Nose Throat J
January 2025
Otolaryngology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Infraorbital ethmoidal air cells (IOEAc) are ethmoidal cells that pneumatizes inferior to the orbital floor and lateral to a line parallel to the lamina papyracea. Studies have shown considerable anatomical variation with different extensions in humans. To identify and categorize the anatomical variations of the IOEAc creating a new, comprehensive variation classification system.
View Article and Find Full Text PDFJ Clin Periodontol
December 2024
Department of Periodontology, Kyung Hee University College of Dentistry, Periodontal-Implant Clinical Research Institute, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Aim: To determine bone regeneration following sinus floor elevation (SFE) at sites with or without prior sinus membrane perforation.
Materials And Methods: The sinus membranes in the maxillary sinuses of 12 rabbits were intentionally perforated (≥ 5 mm) on one side, followed by application of a collagen matrix. SFE was performed on both sinuses after 8 weeks of healing, presenting two groups: SFE with a previous large sinus membrane perforation (group SFE_Perf), and in an intact sinus (group SFE).
Int J Pediatr Otorhinolaryngol
December 2024
Autolab Technologies Pvt. Ltd., Lalitpur, Nepal.
Introduction: Intranasal steroids are effective in managing adenoid hypertrophy in children, but the evidence regarding technique of use for optimal results is lacking.
Methods: CFD analysis, with discrete phase modelling was done to simulate nasal spray in nasal cavity and drug delivery in the region of adenoids. The findings were validated using a 3D model designed from CT scan of the same region.
Int J Implant Dent
December 2024
Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Purpose: Currently, maxillary sinus floor (SF) elevation is based on off-the-shelf allogeneic, xenogeneic or synthetic bone augmentation materials (BAM) that are implanted via an open lateral sinus wall approach (OSFE). However, this invasive method is associated with postoperative complications caused by an inadequate blood supply of the alveolar ridge. Balloon-assisted procedures are minimal invasive alternatives with lower complication rates.
View Article and Find Full Text PDFAm J Transl Res
November 2024
Department of Radioactive Intervention, Henan No. 3 Provincial People's Hospital Zhengzhou 450006, Henan, China.
ECMO is an advanced technology for extracorporeal respiratory and circulatory support. It involves the extraction of venous blood from the patient's body, which is subsequently oxygenated within an oxygenator (or membrane lung). This oxygen-rich blood is reinfused either into veins or arteries, rapidly compensating for impaired lung and heart functionalities.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!